The most challenging aspect of the diagnostic process in ADEM is the differential diagnosis with a first attack of multiple sclerosis (MS), myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD), or neuromyelitis optica spectrum disorder (NMOSD). The gene discussed is OMG; the disease is myeloid sarcoma.